Title of article :
Clinicopathological Features of Non-metastatic Triple Negative Breast Cancer
Author/Authors :
Najafi, Safa Breast Cancer Research Centre - ACECR, Tehran , Mozaffari, Hamid Reza Department of Oral Medicine - School of Dentistry - Kermanshah University of Medical Sciences, Kermanshah - Medical Biology Research Center - Kermanshah University of Medical Sciences, Kermanshah , Sadeghi, Masoud Medical Biology Research Center - Kermanshah University of Medical Sciences, Kermanshah - Student Research Committee - Kermanshah University of Medical Sciences, Kermanshah
Abstract :
Background: Triple negative breast cancer (TNBC) is reported to be associated
with a high risk of recurrence, poor overall survival (OS), and disease-free
survival (DFS) rates. This study evaluated the clincopathological features and
survival of non-metastatic TNBC women in the capital of Iran compared with
other areas of the world.
Methods: In a retrospective study, 119 women with TNBC based on the criteria
were analyzed in this study during 2007-2015. A number of clinicopathological
variables, OS and DFS were determined in all patients. The mean follow-up was
38 months, which 6 patients lost to follow-up and 16 died of the disease and
therefore were censored from the study.
Results: The mean age at diagnosis was 44.9 years (range: 21-85 years). 31.9% were
older than 50 years. The 2- and 5-years OS rates were 96% and 88.1%, respectively;
whereas, the 2- and 5-years DFS rates were 87% and 74.1%, respectively. Right
breast tumor and lymph node involvement were more common in patients
younger than 50 years, but vascular invasion was more observed in patients aged
≥50 years. There was no significant difference between menopause status, age
and Ki-67 index for OS or DFS.
Conclusion: The prevalence of TNBC was more common in women younger
than 50 years. Ki-67 index, menopausal status and age could contribute to
prognosis and survival of patients.
Keywords :
Breast cancer , Overall survival , Disease free survival , Prognostic factors , Triple negative , Estrogen receptor , Progesterone receptor , HER2 receptors
Journal title :
Iranian Journal of Blood and Cancer (IJBC)